← Eichor
Condition: Primary Gout And Hyperuricemia Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Primary Gout And Hyperuricemia

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

The Efficacy and Safety of SHR4640 Tablet Combined With 40 mg Febuxostat Tablets in the Treatment of Primary Gout and Hy
Phase 2 · 1 location(s) · Jiangsu HengRui Medicine Co., Ltd. · NCT07362355Study of Dapansutrile Tablets in Subjects With an Acute Gout Flare
Phase 2/Phase 3 · 40 location(s) · Olatec Therapeutics, Inc. · NCT05658575
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.